INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ModivCare, Inc. of Class Action Lawsuit and Upcoming Deadlines – MODV

Core Viewpoint - A class action lawsuit has been filed against ModivCare, Inc. for alleged securities fraud and unlawful business practices, with investors encouraged to participate in the lawsuit [1][2]. Financial Performance - On May 4, 2023, ModivCare reported a reduction in cash flow from operations, leading to a stock price drop of $11.30 per share, or 16.31%, closing at $58.00 [4]. - On August 3, 2023, the company disclosed a large payable balance affecting cash flow, resulting in a stock price decline of $2.86 per share, or 7.48%, to close at $35.38 [5]. - On February 23, 2024, ModivCare announced negative cash flow and an expectation for this trend to continue, causing a stock price fall of $17.25 per share, or 39.32%, to close at $26.62 [6]. - On September 12, 2024, the company announced actions to seek additional capital, leading to a significant stock price drop of $18.43 per share, or 59.09%, closing at $12.76 [7]. - On September 16, 2024, ModivCare revised its 2024 Adjusted EBITDA guidance downwards, resulting in a stock price decrease of $1.40 per share, or 9.92%, to close at $12.72 [8].